CAS Number: 790302-50-0
Aerial summits are used. It contains galic tannins, phenol-carboxylic acids, flavonoids and iridoid heterosides. The Commission E of German Ministry of Health does not support the traditional use as anti-diarrhea and eye anti-inflammatory agent.
CAS Number: 90045-36-6
Leaves of tree are used.It contains flavonoids, tannins, diterpenes, steroids..Unproved effects: venous tonic, capillary protector, vasodilator (neuron-protector) and platelet anti-aggregationIndications after Commission E of German Ministry of Health: brain vascular insufficiency, intermittent claudication, dizziness, tinnitus. Fluids or solutions with alcoholic content are to be avoided.
CAS Number: 50-81-7
Vitamin C is abundantly present in food. A balanced and comprehensive diet makes vitamin supplementation useless. Any amount of vitamin C taken by the mother as a supplement does not affect significantly the concentration in breast milk of women who are on a varied and balanced diet.
CAS Number: 554-13-2
It is excreted into breast milk in amounts that may be clinically significant and can be as high as a half of that reached in mother’s plasma and up to one third of the therapeutic level in the infant. In infants and newborns (5 days), premature babies and dehydrated or infected infants, who may show reduced clearance mechanisms for lithium, there have been reports of clear signs of lithium toxicity caused by ingestion of breast milk: cyanosis, lethargy, hypotonia or slight increase in TSH. However, there are numerous cases of infants whose mothers were on lithium who did not show any clinical, growth or neurodevelopmental problem at the short or long term. Breastfeeding is less risky for healthy term infants whose mothers are treated with lithium when she or her family has capacity enough to monitor the occurrence of adverse effects, medical supervision and, whenever necessary, monitoring of lithium levels in the mother-infant dyad. Mothers should stop taking lithium 1 to 2 days before delivery or cesarean section in order to decrease plasma levels in the newborn. Lithium may be, or not, a cause of increased Prolactin and galactorrhea.
CAS Number: 303-98-0
We are working on a comment for this product.
CAS Number: 7440-57-5
One case of facial edema that was barely related to this drug has been described. It has an extremely long half-life span.
Climbing plant. The female inflorescences or flower tips are used.It contains phloroglucinols, estrogenic, quercetin, kaempferol, tannins, phenolic acids essential oil and flavonoids. One of its components, 8-prenylnaringenin (8-PN) is the most powerful phytoestrogen known. Properties that are attributed: hypnotic, sedative, orexigenic.It is used as a flavoring and stabilizer of the beer.Indications German Commission E Ministry of Health, EMA and ESCOP: insomnia, nervousness, anxiety There is no scientific evidence showing an improvement in milk production.A possible estrogenic effect may be a decrease in milk production.The best galactogogue is a frequent and on-demand breastfeeding along with proper technique. During breastfeeding its consumption should be moderate or occasional.
Various calcium salts (Acetate, Carbonate, Chloride, Citrate, Phosphate, Gluceptate, Glucobionato, Lactate, Laxctobionato Pidolate, Silicate) are used in the management of hypocalcemia, supplements for treating calcium deficiency states and antacids ( Carbonate and Silicate) Daily requirement of calcium during lactation are 1 g (1.3 g in children under 20 years).Calcium supplements in the diet does not affect the concentration of calcium in milk.Excessive intake of calcium is not good for health. During lactation, consumption of calcium should not exceed 2.5 g a day. WHO List of Essential Medicines 2002 states that it is compatible with breastfeeding.
CAS Number: 90045-36-6
Ginkgo (Ginkgo biloba) leaf contains flavonoids (e.g., quercetin, kaempferol, isorhamnetine) and several terpene trilactones (e.g., ginkgolides, bilobalide) as well as numerous minor components. Standardization is based on ginkgo flavone glycoside and terpenoid content. Raw ginkgo seeds contain potentially toxic cyanogenic glycosides and should not be used; roasted seeds do not carry this risk. Ginkgo has no specific uses during breastfeeding, but is commonly used as an antioxidant, a vasodilator to increase cerebral and peripheral perfusion, and to improve memory. No data exist on the safety and efficacy of ginkgo in nursing mothers or infants. In general, it is well tolerated, but occasionally minor symptoms (e.g., headache, nausea, gastrointestinal complaints, allergic skin rashes) occur in those taking the drug. Ginkgo has caused some cases of bleeding in healthy volunteers caused by its antiplatelet activity. Because there is no published experience with ginkgo during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant.[1] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 84082-34-8
Bilberry (Vaccinium myrtillus) fruit contains tannins and anthocyanidins. Bilberry is most often used for eye disorders. Bilberry was reportedly used as a European folk medicine to stop milk flow. No data exist on the excretion of any components of bilberry into breastmilk or on the safety and efficacy of bilberry in nursing mothers or infants. Bilberry preparations are generally well tolerated as a food, but should be avoided in patients allergic to bilberry, cranberry, blueberry, and other Vaccinium species. No recommendations can be made on the use of large quantities of bilberry products during breastfeeding. Dietary supplements do not require pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 554-13-2
Although lithium appears on many lists of drugs contraindicated during breastfeeding, other sources do not consider it an absolute contraindication, especially in infants over 2 months of age and during lithium monotherapy.[1][2][3][4] Numerous reports exist of infants who were breastfed during maternal lithium therapy without any signs of toxicity or developmental problems. Most were breastfed from birth and some continued to nurse for up to 1 year of maternal lithium therapy. Limited data suggest that lithium in milk can adversely affect the infant when its elimination is impaired, as in dehydration or in newborn or premature infants. Neonates may also have transplacentally acquired serum lithium levels. Because maternal lithium requirements and dosage may be increased during pregnancy, maternal serum levels should be monitored frequently postpartum and dosage reduced as necessary to avoid excessive infant exposure via breastmilk.[5] The long-term effects of lithium on infants are not certain, but limited data indicate no obvious problems in growth and development.[6] Lithium may be used in mothers of fullterm infants who are willing and able to monitor their infants. Discontinuing lithium 24 to 48 hours before Cesarean section delivery or at the onset of spontaneous labor and resuming the prepregnancy lithium dose immediately after delivery should minimize the infant's serum lithium concentration at birth.[7] Some investigators recommend monitoring infant serum lithium, serum creatinine, BUN, and TSH in intervals ranging from "periodic" to every 4 to 12 weeks during breastfeeding and maternal lithium therapy.[3][8][9] However, others recommend close pediatric follow-up of the infant and only selective laboratory monitoring as clinically indicated.[7] Breastfeeding should be discontinued immediately and the infant evaluated if the infant appears restless or lethargic or has feeding problems.[7]
CAS Number: 1339-63-5
Coenzyme Q10 (ubiquinone) is a normal part of the diet, and is also endogenously synthesized. It is a normal component of human milk, but milk levels are slightly low in the breastmilk of mothers with preterm infants. Coenzyme Q10 has no specific lactation-related uses and no data exist on the safety and efficacy of supplementation in nursing mothers or infants. Coenzyme Q10 supplements are usually well tolerated with only infrequent, minor side effects. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 7704-34-9
Sulfur 5% to 10% in a petrolatum base is safe for topical use in children, including infants under 2 months of age.[1] This makes it a useful alternative to organic insecticides for treating scabies in nursing mothers; however, the petrolatum base makes undesirable for use on the breast.
Next to calcium, phosphorus is the most abundant mineral in the body, making up about 1% of total body weight. Calcium, which gives strength to bones and teeth, needs to be combined with another mineral, such as phosphorous, to become stabilized before it can be effective.
Phosphorus also helps to release energy from food as it plays an important role in the metabolism of carbohydrate, fat and protein. Phosphorus is naturally found in many food sources and phosphorus supplementation while breastfeeding is mostly safe.
You can easily get all the phosphorus you need from a well-balanced diet (even though most prenatal vitamins dont contain phosphorus). For example, 2 cup of yogurt provides nearly all your phosphorus for the day.
Warning: Consuming high doses of phosphorus for a short time can cause diarrhea or stomach pain. The long term over-consumption of foods high in phosphorus can deplete calcium resources and lead to reduced bone mass, which means that bones are more likely to fracture.Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Occuloplex G | Bioactive Nutritional, Inc. is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.
Homeopathic medicines are usually safe in breastfeeding and if Occuloplex G | Bioactive Nutritional, Inc. has been recommended by doctor then there should be no concern about its usage in breastfeeding.
Not exactly.
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week